Thursday, 25 November 2010

Vitamin D3-Doms Adrian




Vitamin D3-Doms Adrian may be available in the countries listed below.


Ingredient matches for Vitamin D3-Doms Adrian



Colecalciferol

Colecalciferol is reported as an ingredient of Vitamin D3-Doms Adrian in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, 20 November 2010

Postanesthetic Shivering Medications


Drugs associated with Postanesthetic Shivering

The following drugs and medications are in some way related to, or used in the treatment of Postanesthetic Shivering. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:

Litijum karbonat




Litijum karbonat may be available in the countries listed below.


Ingredient matches for Litijum karbonat



Lithium

Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Litijum karbonat in the following countries:


  • Serbia

International Drug Name Search

Thursday, 18 November 2010

Dialens




Dialens may be available in the countries listed below.


Ingredient matches for Dialens



Dextran

Dextran average molecular weight about 70000 (a derivative of Dextran) is reported as an ingredient of Dialens in the following countries:


  • Switzerland

International Drug Name Search

Tuesday, 16 November 2010

Chlortetracycline Pneumonia




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chlortetracycline Pneumonia



Chlortetracycline

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Chlortetracycline Pneumonia in the following countries:


  • United States

International Drug Name Search

Monday, 15 November 2010

Lazanda


Lazanda is a brand name of fentanyl, approved by the FDA in the following formulation(s):


LAZANDA (fentanyl citrate - spray, metered; nasal)



  • Manufacturer: ARCHIMEDES

    Approval date: June 30, 2011

    Strength(s): EQ 0.1MG BASE, EQ 0.4MG BASE [RLD]

Has a generic version of Lazanda been approved?


No. There is currently no therapeutically equivalent version of Lazanda available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lazanda. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pectin compositions and methods of use for improved delivery of drugs to mucosal surfaces
    Patent 6,432,440
    Issued: August 13, 2002
    Inventor(s): Peter James; Watts & Lisbeth; Illum
    Assignee(s): West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited
    Liquid pharmaceutical compositions for administration to a mucosal surface, comprising a therapeutic agent and a pectin with a low degree of esterification are described. Such compositions gel, or can be adapted to gel, at the site of application in the absence of an extraneous source of divalent metal ions.
    Patent expiration dates:

    • April 20, 2018
      ✓ 
      Patent use: MANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT CANCER PAIN
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 30, 2014 - NEW DOSAGE FORM

See also...

  • Lazanda Consumer Information (Drugs.com)
  • Lazanda Spray Consumer Information (Wolters Kluwer)
  • Lazanda nasal Consumer Information (Cerner Multum)
  • Fentanyl Consumer Information (Drugs.com)
  • Fentanyl Consumer Information (Wolters Kluwer)
  • Fentanyl Lozenge Consumer Information (Wolters Kluwer)
  • Fentanyl Patch Consumer Information (Wolters Kluwer)
  • Fentanyl Soluble Film Consumer Information (Wolters Kluwer)
  • Fentanyl Spray Consumer Information (Wolters Kluwer)
  • Fentanyl Tablet Consumer Information (Wolters Kluwer)
  • Fentanyl buccal Consumer Information (Cerner Multum)
  • Fentanyl citrate oral transmucosal Consumer Information (Cerner Multum)
  • Fentanyl nasal Consumer Information (Cerner Multum)
  • Fentanyl sublingual Consumer Information (Cerner Multum)
  • Fentanyl transdermal device Consumer Information (Cerner Multum)
  • Fentanyl transdermal skin patch Consumer Information (Cerner Multum)
  • Fentanyl Buccal mucosa, Oromucosal Advanced Consumer Information (Micromedex)
  • Fentanyl Nasal Advanced Consumer Information (Micromedex)
  • Fentanyl Transdermal Advanced Consumer Information (Micromedex)
  • Fentanyl Citrate AHFS DI Monographs (ASHP)

Friday, 12 November 2010

Selectol




Selectol may be available in the countries listed below.


Ingredient matches for Selectol



Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Selectol in the following countries:


  • Austria

  • Belgium

  • Chile

  • Finland

  • Germany

  • Greece

  • Hong Kong

  • Ireland

  • Japan

  • Luxembourg

  • Switzerland

International Drug Name Search